JP2020501574A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020501574A5 JP2020501574A5 JP2019533142A JP2019533142A JP2020501574A5 JP 2020501574 A5 JP2020501574 A5 JP 2020501574A5 JP 2019533142 A JP2019533142 A JP 2019533142A JP 2019533142 A JP2019533142 A JP 2019533142A JP 2020501574 A5 JP2020501574 A5 JP 2020501574A5
- Authority
- JP
- Japan
- Prior art keywords
- transcription
- nucleic acid
- component
- acid sequence
- transcription system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000013518 transcription Methods 0.000 claims description 81
- 230000035897 transcription Effects 0.000 claims description 81
- 150000007523 nucleic acids Chemical class 0.000 claims description 61
- 210000004027 cell Anatomy 0.000 claims description 36
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 34
- 239000003795 chemical substances by application Substances 0.000 claims description 32
- 108091023040 Transcription factor Proteins 0.000 claims description 30
- 102000040945 Transcription factor Human genes 0.000 claims description 30
- 238000003032 molecular docking Methods 0.000 claims description 28
- 102000039446 nucleic acids Human genes 0.000 claims description 23
- 108020004707 nucleic acids Proteins 0.000 claims description 23
- 239000013598 vector Substances 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 16
- 239000011230 binding agent Substances 0.000 claims description 14
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 13
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 12
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 108010021152 pepBs1-Ac peptide Proteins 0.000 claims description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 230000024245 cell differentiation Effects 0.000 claims description 5
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims description 4
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 claims description 4
- 108020004414 DNA Proteins 0.000 claims description 4
- 108010077850 Nuclear Localization Signals Proteins 0.000 claims description 4
- 239000004098 Tetracycline Substances 0.000 claims description 4
- 230000004186 co-expression Effects 0.000 claims description 4
- 229960003722 doxycycline Drugs 0.000 claims description 4
- 239000012636 effector Substances 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229960004023 minocycline Drugs 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 230000000717 retained effect Effects 0.000 claims description 4
- 229960002180 tetracycline Drugs 0.000 claims description 4
- 229930101283 tetracycline Natural products 0.000 claims description 4
- 235000019364 tetracycline Nutrition 0.000 claims description 4
- 150000003522 tetracyclines Chemical class 0.000 claims description 4
- 102100021631 B-cell lymphoma 6 protein Human genes 0.000 claims description 2
- 102000012666 Core Binding Factor Alpha 3 Subunit Human genes 0.000 claims description 2
- 108010079362 Core Binding Factor Alpha 3 Subunit Proteins 0.000 claims description 2
- 102100039436 DNA-binding protein inhibitor ID-3 Human genes 0.000 claims description 2
- 108700022150 Designed Ankyrin Repeat Proteins Proteins 0.000 claims description 2
- 102100030751 Eomesodermin homolog Human genes 0.000 claims description 2
- -1 FOX01 Proteins 0.000 claims description 2
- 102000016359 Fibronectins Human genes 0.000 claims description 2
- 108010067306 Fibronectins Proteins 0.000 claims description 2
- 101000971234 Homo sapiens B-cell lymphoma 6 protein Proteins 0.000 claims description 2
- 101001081582 Homo sapiens DNA-binding protein inhibitor ID-2 Proteins 0.000 claims description 2
- 101001036287 Homo sapiens DNA-binding protein inhibitor ID-3 Proteins 0.000 claims description 2
- 101001064167 Homo sapiens Eomesodermin homolog Proteins 0.000 claims description 2
- 101001045751 Homo sapiens Hepatocyte nuclear factor 1-alpha Proteins 0.000 claims description 2
- 101000972291 Homo sapiens Lymphoid enhancer-binding factor 1 Proteins 0.000 claims description 2
- 101000687344 Homo sapiens PR domain zinc finger protein 1 Proteins 0.000 claims description 2
- 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 claims description 2
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 claims description 2
- 101000904499 Homo sapiens Transcription regulator protein BACH2 Proteins 0.000 claims description 2
- 102100022699 Lymphoid enhancer-binding factor 1 Human genes 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 108010066154 Nuclear Export Signals Proteins 0.000 claims description 2
- 102100024894 PR domain zinc finger protein 1 Human genes 0.000 claims description 2
- 108091008778 RORγ2 Proteins 0.000 claims description 2
- 102000009661 Repressor Proteins Human genes 0.000 claims description 2
- 102100036840 T-box transcription factor TBX21 Human genes 0.000 claims description 2
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 claims description 2
- 102100030627 Transcription factor 7 Human genes 0.000 claims description 2
- 102100023998 Transcription regulator protein BACH2 Human genes 0.000 claims description 2
- 108091008108 affimer Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 229930193936 anticarin Natural products 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 210000000170 cell membrane Anatomy 0.000 claims description 2
- 210000000805 cytoplasm Anatomy 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 230000004807 localization Effects 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 230000035772 mutation Effects 0.000 claims description 2
- 150000003384 small molecules Chemical group 0.000 claims description 2
- 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 claims description 2
- 230000002103 transcriptional effect Effects 0.000 claims 6
- 230000004069 differentiation Effects 0.000 claims 1
- 238000010361 transduction Methods 0.000 claims 1
- 230000026683 transduction Effects 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002463 transducing effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1621891.9A GB201621891D0 (en) | 2016-12-21 | 2016-12-21 | Transcription system |
| GB1621891.9 | 2016-12-21 | ||
| PCT/GB2017/053835 WO2018115866A1 (en) | 2016-12-21 | 2017-12-20 | Transcription system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020501574A JP2020501574A (ja) | 2020-01-23 |
| JP2020501574A5 true JP2020501574A5 (enExample) | 2020-12-03 |
| JP7117304B2 JP7117304B2 (ja) | 2022-08-12 |
Family
ID=58284377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533142A Active JP7117304B2 (ja) | 2016-12-21 | 2017-12-20 | 転写システム |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200095590A1 (enExample) |
| EP (1) | EP3559235A1 (enExample) |
| JP (1) | JP7117304B2 (enExample) |
| CN (1) | CN110114466A (enExample) |
| AU (1) | AU2017381419A1 (enExample) |
| CA (1) | CA3047622A1 (enExample) |
| GB (1) | GB201621891D0 (enExample) |
| WO (1) | WO2018115866A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3662055A1 (en) * | 2017-08-02 | 2020-06-10 | Autolus Limited | Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressed |
| WO2019210863A1 (zh) * | 2018-05-03 | 2019-11-07 | 科济生物医药（上海）有限公司 | 免疫效应细胞及其应用 |
| US20210363217A1 (en) * | 2018-06-19 | 2021-11-25 | Autolus Limited | Cell |
| WO2020141106A1 (en) * | 2019-01-03 | 2020-07-09 | Kemijski Institut | Engineered externally regulated artificial transcription regulatory system based on engineered nfat |
| GB201903237D0 (en) | 2019-03-08 | 2019-04-24 | Autolus Ltd | Method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL128017A0 (en) * | 1998-07-22 | 1999-11-30 | Technion Res & Dev Foundation | Method for detecting protein-protein interactions and a kit therefor |
| DE60104019T2 (de) * | 2000-12-18 | 2005-07-14 | National Research Council Of Canada, Ottawa | Zusammensetzungen, Verfahren und Reagentiensätze zur Erkennung von Protein-Protein Wechselwirkung störenden Substanzen |
| GB201415347D0 (en) * | 2014-08-29 | 2014-10-15 | Ucl Business Plc | Signalling system |
| US10688166B2 (en) * | 2014-11-03 | 2020-06-23 | Cerus Corporation | Compositions and methods for improved car-T cell therapies |
| WO2016138034A1 (en) * | 2015-02-24 | 2016-09-01 | The Regents Of The University Of California | Binding-triggered transcriptional switches and methods of use thereof |
-
2016
- 2016-12-21 GB GBGB1621891.9A patent/GB201621891D0/en not_active Ceased
-
2017
- 2017-12-20 JP JP2019533142A patent/JP7117304B2/ja active Active
- 2017-12-20 AU AU2017381419A patent/AU2017381419A1/en not_active Abandoned
- 2017-12-20 WO PCT/GB2017/053835 patent/WO2018115866A1/en not_active Ceased
- 2017-12-20 EP EP17822746.8A patent/EP3559235A1/en active Pending
- 2017-12-20 CN CN201780079675.1A patent/CN110114466A/zh active Pending
- 2017-12-20 US US16/470,965 patent/US20200095590A1/en active Pending
- 2017-12-20 CA CA3047622A patent/CA3047622A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Utz et al. | Early fate defines microglia and non-parenchymal brain macrophage development | |
| JP2020501574A5 (enExample) | ||
| Drummond et al. | Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors | |
| Mowel et al. | Group 1 innate lymphoid cell lineage identity is determined by a cis-regulatory element marked by a long non-coding RNA | |
| JP2020511115A5 (enExample) | ||
| Agbu et al. | The small GTPase RSG1 controls a final step in primary cilia initiation | |
| WO2016143826A1 (ja) | 多能性幹細胞を所望の細胞型へ分化する方法 | |
| CN110520167B (zh) | 稳定的三维血管和形成其的方法 | |
| Bhalla et al. | Thymus functionality needs more than a few TECs | |
| Johnson et al. | Autophagic state prospectively identifies facultative stem cells in the intestinal epithelium | |
| Tenno et al. | Cbfβ2 controls differentiation of and confers homing capacity to prethymic progenitors | |
| May et al. | Neuronal-epithelial cross-talk drives acinar specification via NRG1-ERBB3-mTORC2 signaling | |
| Auler et al. | miR-127-3p is an epigenetic activator of myofibroblast senescence situated within the microRNA-enriched Dlk1-Dio3‒imprinted domain on mouse chromosome 12 | |
| Yamamoto et al. | In vitro generation of brain regulatory T cells by co-culturing with astrocytes | |
| US20200095590A1 (en) | Transcription system | |
| Wang et al. | Resolving the lineage relationship between malignant cells and vascular cells in glioblastomas | |
| Mansour et al. | The centrosomal protein 83 (CEP83) regulates human pluripotent stem cell differentiation toward the kidney lineage | |
| KR20210029272A (ko) | 혈뇌장벽을 통과하는 압타머 및 그것의 응용 | |
| Kumar et al. | Germ cell-specific sustained activation of Wnt signalling perturbs spermatogenesis in aged mice, possibly through non-coding RNAs | |
| Vervenne et al. | Lpp is involved in Wnt/PCP signaling and acts together with Scrib to mediate convergence and extension movements during zebrafish gastrulation | |
| Wei et al. | A focused in situ hybridization screen identifies candidate transcriptional regulators of thymic epithelial cell development and function | |
| Tiemann et al. | Pancreatic alpha and beta cell fate choice is directed by apical-basal polarity dynamics | |
| US11179479B2 (en) | Enhanced cardiomyocyte regeneration | |
| CN116472349A (zh) | Line1的抑制剂及其用途 | |
| CN119497750A (zh) | 产生小胶质细胞的方法和组合物 |